BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He Y, Lu H, Zhang L. Serum AFP levels in patients suffering from 47 different types of cancers and noncancer diseases. Prog Mol Biol Transl Sci 2019;162:199-212. [PMID: 30905450 DOI: 10.1016/bs.pmbts.2019.01.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Montaño-Samaniego M, Bravo-Estupiñan DM, Méndez-Guerrero O, Alarcón-Hernández E, Ibáñez-Hernández M. Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters. Front Oncol 2020;10:605380. [PMID: 33381459 DOI: 10.3389/fonc.2020.605380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Yuan G, Xie H, Wei T, Zhu D, Zhang C, Yang Y. Diagnostic potential of extracellular vesicle-associated microRNA-10b and tumor markers for lung adenocarcinoma. Oncol Lett 2021;22:614. [PMID: 34257722 DOI: 10.3892/ol.2021.12875] [Reference Citation Analysis]
3 Asadollahi R, Britschgi C, Joset P, Oneda B, Schindler D, Meier UR, Rauch A. Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia-telangiectasia mutated gene). Mol Genet Genomic Med 2020;8:e1409. [PMID: 32748564 DOI: 10.1002/mgg3.1409] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Yang J, Li X, Wei S, Peng L, Sang H, Jin D, Chen M, Dang Y, Zhang G. Evaluation of the Diagnostic Potential of a Plasma Exosomal miRNAs Panel for Gastric Cancer. Front Oncol 2021;11:683465. [PMID: 34422636 DOI: 10.3389/fonc.2021.683465] [Reference Citation Analysis]
5 Isac T, Isac S, Ioanitescu S, Mihaly E, Tanasescu MD, Balan DG, Tulin A, Iliescu L. Dynamics of serum α-fetoprotein in viral hepatitis C without hepatocellular carcinoma. Exp Ther Med 2021;22:749. [PMID: 34035846 DOI: 10.3892/etm.2021.10181] [Reference Citation Analysis]
6 Jiang N, Tian T, Chen X, Zhang G, Pan L, Yan C, Yang G, Wang L, Cao X, Wang X. A Diagnostic Analysis Workflow to Optimal Multiple Tumor Markers to Predict the Nonmetastatic Breast Cancer from Breast Lumps. J Oncol 2021;2021:5579373. [PMID: 34335759 DOI: 10.1155/2021/5579373] [Reference Citation Analysis]
7 Zhang M, Dou H, Yang D, Shan M, Li X, Hao C, Zhang Y, Zeng P, He Y, Liu Y, Fu J, Wang W, Hu M, Li H, Tian Q, Lei S, Zhang L. Retrospective analysis of glycan-related biomarkers based on clinical laboratory data in two medical centers during the past 6 years. Prog Mol Biol Transl Sci 2019;162:141-63. [PMID: 30905446 DOI: 10.1016/bs.pmbts.2019.01.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Rochigneux P, Chanez B, De Rauglaudre B, Mitry E, Chabannon C, Gilabert M. Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials. Cancers (Basel). 2021;13. [PMID: 33450845 DOI: 10.3390/cancers13020271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Liu W, Kang Q, Wang P, Zhou F. Ratiometric fluorescence immunoassay based on MnO 2o -phenylenediamine–fluorescent carbon nanodots for the detection of α -fetoprotein via fluorescence resonance energy transfer. New J Chem 2022;46:1120-6. [DOI: 10.1039/d1nj04787f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]